Viatris Inc (NAS:VTRS)
$ 11.62 0 (0%) Market Cap: 13.87 Bil Enterprise Value: 30.11 Bil PE Ratio: 0 PB Ratio: 0.71 GF Score: 71/100

Viatris Inc at Barclays Global Healthcare Conference Transcript

Mar 16, 2022 / 02:45PM GMT
Release Date Price: $10.39 (+4.32%)
Balaji V. Prasad
Barclays Bank PLC, Research Division - Director

Good morning, everyone. Welcome to Day 2 of the Barclays Healthcare Conference. Continuing the [spectrum] track for the day, I'm delighted to have the management of Viatris with me. Just like what the slide says, we have Mike Goettler, the CEO of Viatris with us; and Rajiv Malik, President; and Sanjeev Narula, the CFO.

Questions & Answers

Balaji V. Prasad
Barclays Bank PLC, Research Division - Director

So starting with -- this is going to be a fireside comment -- fireside chat format. And really since the last 15 days, Mike and Rajiv, Sanjeev, in further discussions, right, think -- I don't think you would have expected the reaction to your announcement, the way the stock has reacted. Investors are understandably in angst. So let's speak about capital allocation. Basically, what do you think about the biosimilars business and exiting the business and then investing in the newer assets, which is asset undisclosed or newer areas? And how do you think competitors, in terms of, like, the

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot